| Dr Michael Martin Vanvliet, MD | |
|
2020 59th St W, Bradenton, FL 34209-4604 | |
| (706) 863-9595 | |
| (706) 868-8375 |
| Full Name | Dr Michael Martin Vanvliet |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 18 Years |
| Location | 2020 59th St W, Bradenton, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841372968 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME123837 (Florida) | Primary |
| 2086S0102X | Surgery - Surgical Critical Care | ME123837 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nurse On Call | Bradenton, FL | Home health agency |
| Blake Medical Center | Bradenton, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Florida Physician Network, Llc | 1153476544 | 42 |
News Archive
One of the most difficult-to-remove tumors located deep in the midbrain area can now be safely excised thanks to the work of one Los Angeles surgeon. Hrayr Shahinian, M.D., medical director of The Skull Base Institute in Los Angeles, has developed a minimally invasive approach to removing pineal tumors so called as they are shaped like pine cones.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology, highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology's 2010 Annual Meeting, comparing percutaneous hepatic perfusion with melphalan to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma.
Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I).
News outlets also report that states are still conducting outreach efforts and offering the latest tallies of people who are signing up as well as information about subsidies.
› Verified 1 days ago
| Entity Name | West Florida Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376779496 PECOS PAC ID: 1153476544 Enrollment ID: O20090909000250 |
News Archive
One of the most difficult-to-remove tumors located deep in the midbrain area can now be safely excised thanks to the work of one Los Angeles surgeon. Hrayr Shahinian, M.D., medical director of The Skull Base Institute in Los Angeles, has developed a minimally invasive approach to removing pineal tumors so called as they are shaped like pine cones.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology, highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology's 2010 Annual Meeting, comparing percutaneous hepatic perfusion with melphalan to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma.
Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I).
News outlets also report that states are still conducting outreach efforts and offering the latest tallies of people who are signing up as well as information about subsidies.
› Verified 1 days ago
| Entity Name | Luminary Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851955983 PECOS PAC ID: 8628301835 Enrollment ID: O20190603002014 |
News Archive
One of the most difficult-to-remove tumors located deep in the midbrain area can now be safely excised thanks to the work of one Los Angeles surgeon. Hrayr Shahinian, M.D., medical director of The Skull Base Institute in Los Angeles, has developed a minimally invasive approach to removing pineal tumors so called as they are shaped like pine cones.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology, highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology's 2010 Annual Meeting, comparing percutaneous hepatic perfusion with melphalan to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma.
Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I).
News outlets also report that states are still conducting outreach efforts and offering the latest tallies of people who are signing up as well as information about subsidies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Martin Vanvliet, MD Po Box 3725, Augusta, GA 30914-3725 Ph: (706) 863-9595 | Dr Michael Martin Vanvliet, MD 2020 59th St W, Bradenton, FL 34209-4604 Ph: (706) 863-9595 |
News Archive
One of the most difficult-to-remove tumors located deep in the midbrain area can now be safely excised thanks to the work of one Los Angeles surgeon. Hrayr Shahinian, M.D., medical director of The Skull Base Institute in Los Angeles, has developed a minimally invasive approach to removing pineal tumors so called as they are shaped like pine cones.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology, highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology's 2010 Annual Meeting, comparing percutaneous hepatic perfusion with melphalan to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma.
Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I).
News outlets also report that states are still conducting outreach efforts and offering the latest tallies of people who are signing up as well as information about subsidies.
› Verified 1 days ago
Daniel B Westawski, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2020 59th St W, Bradenton, FL 34209 Phone: 706-863-9595 Fax: 706-868-8375 | |
Dr. Robin Rene Hamlin, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5105 Manatee Ave W, Suite 18, Bradenton, FL 34209 Phone: 941-798-9777 Fax: 941-795-5177 | |
Jacqueline Frannie Royce, D.O. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 357 6th Ave. W., Bradenton, FL 34205 Phone: 941-358-3223 Fax: 941-358-8422 | |
Dr. Melinda L Lacerna-kimbrell, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5301 4th Avenue Cir E, Bradenton, FL 34208 Phone: 941-954-4500 |